PAL: Practical Approach to Lung Health

Objectives

The Practical Approach to Lung Health (PAL) integrates with the Directly Observed Treatment, Short-course strategy to strengthen tuberculosis control and improve comprehensive primary-care management of common respiratory diseases through locally adapted health-system action.[1]Its overall clinical purpose is to improve assessment, diagnosis, treatment, follow-up, referral, health education and self-management across acute and chronic respiratory conditions.[2][3][4]

• Strengthen symptom-based primary-care assessment, clinical vigilance, diagnostic practice, disease classification and coding, and hierarchical referral arrangements.[2]

• Develop locally appropriate clinical practice guidance aligned with international recommendations, covering respiratory presentations including asthma, chronic obstructive pulmonary disease, bronchiectasis, tuberculosis, allergic rhinitis and acute respiratory illness.[2][3][5]

• Build health-worker knowledge and skills for the diagnosis and management of common respiratory diseases.[2]

• Improve asthma control by minimising daytime and night-time symptoms, exacerbations, short-acting beta agonist use and activity limitation, while using inhaled corticosteroids as preventive treatment and only using long-acting beta agonists together with inhaled corticosteroids.[6]

• Incorporate tobacco-dependence assessment, smoking cessation and motivational support into respiratory care.[2][7]

• Promote pulmonary rehabilitation, including education, exercise, symptom management, nutritional, psychological, family and social support for people with chronic respiratory disease.[2][8]

• Support tuberculosis case finding through identification, registration, sputum examination, referral and treatment initiation for people with suspected disease.[4][9]

• Provide patient education on asthma control, inhaler use, peak expiratory flow, chronic obstructive pulmonary disease self-management, exercise, nutrition, cough etiquette, postural drainage and immunisation.[10][11][12]

Implementation

PAL is implemented through the National Programme for Tuberculosis Control and Chest Diseases in collaboration with the World Health Organization Regional Office for South-East Asia and the World Health Organization country office.[1]Delivery combines symptom-based clinical pathways in primary care with diagnostic tools, treatment protocols, follow-up, self-management support and referral to physicians, chest physicians and other specialists where clinical risk or inadequate response requires escalation.[1][5][13]

• Engage national health authorities, programme personnel, chest physicians, community physicians, senior registrars, technical experts and PAL initiative members in developing and introducing the approach.[2]

• Assess respiratory presentations using symptoms, history, examination and relevant tests, including spirometry, peak expiratory flow, bronchodilator reversibility testing, oximetry and condition-specific questionnaires.[14][15][9]

• Use structured asthma review to assess recent symptoms, night waking, activity limitation and reliever use; reinforce inhaler technique, document peak expiratory flow, provide a self-management plan and arrange follow-up.[6]

• Escalate asthma care for poor control by assessing adherence, inhaler technique, tobacco exposure, allergic rhinitis, medicines and environmental triggers, adjusting treatment, and referring people who remain uncontrolled on high-dose inhaled corticosteroids.[6][16]

• Manage acute asthma through repeated severity assessment, bronchodilators, systemic corticosteroids and escalation, observation or referral according to response.[16]

• Manage acute bronchitis principally with supportive care, bronchodilators, antipyretics, avoidance of toxic exposure and smoking cessation, reserving antibiotics for less common bacterial causes.[14]

• Manage chronic bronchitis and chronic obstructive pulmonary disease exacerbations through assessment of breathlessness and sputum changes, bronchodilators, selected antibiotics or steroids where appropriate, controlled oxygen therapy, smoking cessation and pulmonary rehabilitation.[14][17]

• Deliver inhaled treatment using metered-dose inhalers, spacers, bottle spacers or nebulisers, supported by guidance on preparation, breathing technique, equipment cleaning, storage and performance checks.[18][19][20]

• Apply the 5As approach to cessation support by asking about tobacco use, advising cessation, assessing readiness, assisting with coping strategies and treatment where available, and arranging follow-up or referral; use the 5Rs to strengthen motivation among people not ready to quit.[7][8]

• Provide pulmonary rehabilitation and home-based support through breathing techniques, controlled coughing, flexibility, aerobic and strengthening exercise, with clinical assessment and medical approval before starting an exercise routine.[8][21][22]

• Identify tuberculosis suspects through persistent cough, haemoptysis, constitutional symptoms and relevant risk factors; record them in the tuberculosis suspects register, verify addresses, arrange sputum microscopy and refer positive cases for evaluation, registration and treatment.[4][9]

• Collect influenza-like illness specimens using defined clinical and exposure criteria and nasal or throat swabs in viral transport medium, with other respiratory specimen types identified where appropriate.[4]

• Use individual clinical monitoring tools, including asthma-control classification and peak expiratory flow, the Fagerström Test for Nicotine Dependence, the BODE index for chronic obstructive pulmonary disease, the chronic obstructive pulmonary disease assessment test, and tuberculosis-register review during district chest clinic supervisory visits.[6][7][8][9][11]

Monitoring & Evaluation

Monitoring is principally clinical and patient-level rather than a defined programme-wide performance framework. The material supports symptom assessment, physiological testing, treatment review, self-management monitoring and selected registers, but does not set out consolidated indicators, reporting schedules, surveillance arrangements, evaluation methods, targets or formal accountability structures for the Practical Approach to Lung Health programme.[1][2][3][5][13]

• Use asthma-control classifications based on daytime and night-time symptoms, activity limitation, exacerbations and short-acting beta agonist use; record peak expiratory flow rate and a personal best value during stable control to inform self-management planning.[6]
• Review asthma control after treatment changes, reinforce inhaler technique, assess adherence and exposure to smoking or other triggers, and arrange follow-up within one to three months for stable patients.[6][16]
• Reassess acute asthma after initial treatment, including peak expiratory flow at one and four hours, clinical response, oxygenation and signs of severe illness; use predicted or personal-best peak expiratory flow values to support decisions on discharge, observation or referral.[16]
• Assess asthma severity through symptom frequency, activity limitation, hospitalised attacks, rescue-medication use, peak expiratory flow rate and forced expiratory volume in one second; register patients classified as having persistent asthma.[23]
• Use spirometry, peak-flow variability and bronchodilator reversibility testing to assess airflow limitation. Peak-flow measurement is effort-dependent and is not a substitute for spirometry; variability above 20% is described as supportive of asthma, while reversibility may be indicated by specified improvements in forced expiratory volume in one second or peak expiratory flow after bronchodilator treatment.[15]
• Monitor theophylline levels where feasible, as absorption and metabolism may be affected by factors such as febrile illness.[24]
• Use the Asthma Control Test or related asthma-control questionnaire to assess symptoms, activity limitation, night-time disturbance, rescue treatment use and the patient’s overall view of control, with results reviewed by a clinician.[9][10]
• Use the Chronic Obstructive Pulmonary Disease Assessment Test to measure the impact of disease on wellbeing and daily life and to support treatment discussions with a healthcare professional.[11]
• Assess chronic obstructive pulmonary disease severity using the BODE index, which combines body mass index, airflow obstruction, dyspnoea and exercise capacity; listed measures include post-bronchodilator forced expiratory volume in one second, six-minute walk distance and the modified Medical Research Council dyspnoea scale.[8]
• Use the Fagerström Test for Nicotine Dependence and related questions to assess tobacco dependence, withdrawal symptoms and the likely need for nicotine-replacement treatment.[20][7]
• Check nebuliser function and consult troubleshooting guidance where misting is uneven, as part of equipment-quality monitoring.[20]
• Record tuberculosis suspects and associated information in the tuberculosis suspects register, verify addresses, refer for sputum examination and obtain microscopy or district chest clinic results. The register should be available for supervisory review by the district chest clinic.[9]
• Use clinical assessment for influenza-like illness specimen collection and tuberculosis suspect identification, including symptom and risk-factor screening and examination of at least three sputum samples on consecutive days for tuberculosis investigation.[4][9]

Although the source includes these clinical assessment, follow-up and supervisory mechanisms, it does not specify aggregated service-coverage, quality, treatment-outcome, referral, tobacco-cessation or rehabilitation indicators. It also does not define a national reporting chain, data-review process, surveillance system, independent evaluation schedule, audit process or sanctions and responsibilities for accountability.[1][2][14][17][25][19][7][4][26][21][12]

Costing & Financing

Costing and financing information is largely absent. Financial assistance for Practical Approach to Lung Health-related work is acknowledged from the OF ATM Project, but no amount, budget line, allocation period, financing framework, funding gap, resource-mobilisation plan or economic assumption is provided.[2]

• Identify clinical resource requirements including medicines, inhalers, spacers, nebulisers, oxygen, spirometry and peak-flow equipment, laboratory specimen-collection materials, tuberculosis microscopy and referral services, but do not assign financial values to these inputs.[6][16][15][4][9]
• Recognise workforce and service inputs such as specialist supervision, clinician review, chest-clinic referral, pulmonary rehabilitation, smoking-cessation support and district supervisory visits, while noting that the source gives no staffing costs, procurement arrangements or recurrent expenditure estimates.[16][7][8][9][11]
• Note that technical guidance on medicines, inhaler devices, nebulisation, rehabilitation, nutrition and patient education does not specify unit costs, affordability assumptions, funding sources or reimbursement arrangements.[25][24][18][19][22][27]

No explicit machine-readable budget, cost, allocation, funding-gap or economic-assumption item is available in the supplied material.[1][2][3][5][13][14][23][6][16][17][15][25][28][29][24][18][19][20][7][8][4][9][10][30][31][26][11][21][22][32][33][27][34][35][36][37][38][39][12]